Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Vascular CalcificationArteriosclerosis
Interventions
DRUG

Alendronate

70mg weekly orally

DRUG

Placebo

weekly orally

Trial Locations (1)

3168

Department of Nephrology, Monash Medical Centre, Clayton

All Listed Sponsors
lead

Monash University

OTHER

NCT00395382 - Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease | Biotech Hunter | Biotech Hunter